Harvard Bioscience Inc SEC filings HBIO
Harvard Bioscience Inc has 1,000 filings in SEC EDGAR's recent list, going back to Nov 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 2, 2026 |
| DEF 14A | Proxy statement | Jan 30, 2026 | Mar 6, 2026 |
| PRE 14A | Preliminary proxy statement | Jan 20, 2026 | Jan 20, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| DEF 14A | Proxy statement | Apr 21, 2025 | Jun 2, 2025 |
| DEFA14A | Additional proxy material | Apr 3, 2024 | — |
| DEF 14A | Proxy statement | Apr 3, 2024 | May 14, 2024 |
| DEF 14A | Proxy statement | Apr 5, 2023 | May 15, 2023 |
| DEF 14A | Proxy statement | Apr 7, 2022 | May 17, 2022 |
| DEFA14A | Additional proxy material | Apr 7, 2022 | — |
| DEFA14A | Additional proxy material | Apr 8, 2021 | — |
| DEF 14A | Proxy statement | Apr 8, 2021 | May 18, 2021 |
| DEFA14A | Additional proxy material | May 26, 2020 | — |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 11, 2020 |
| DEF 14A | Proxy statement | Apr 5, 2019 | May 16, 2019 |
| DEFA14A | Additional proxy material | Apr 5, 2019 | — |
| DEFA14A | Additional proxy material | Apr 6, 2018 | — |
| DEF 14A | Proxy statement | Apr 6, 2018 | May 17, 2018 |
| DEFA14A | Additional proxy material | May 11, 2017 | — |
| DEFA14A | Additional proxy material | Apr 5, 2017 | — |
| DEF 14A | Proxy statement | Apr 5, 2017 | May 18, 2017 |
| DEFA14A | Additional proxy material | May 12, 2016 | — |
| DEF 14A | Proxy statement | May 12, 2016 | Jun 24, 2016 |
| DEFA14A | Additional proxy material | Apr 30, 2015 | — |
| DEFA14A | Additional proxy material | Apr 10, 2015 | — |
| DEF 14A | Proxy statement | Apr 10, 2015 | May 28, 2015 |
| DEFA14A | Additional proxy material | Apr 10, 2014 | — |
| DEF 14A | Proxy statement | Apr 10, 2014 | May 22, 2014 |
| DEFA14A | Additional proxy material | Apr 12, 2013 | — |
| DEF 14A | Proxy statement | Apr 12, 2013 | May 23, 2013 |
| DEFA14A | Additional proxy material | Apr 13, 2012 | — |
| DEF 14A | Proxy statement | Apr 13, 2012 | May 24, 2012 |
| DEFA14A | Additional proxy material | Apr 15, 2011 | — |
| DEF 14A | Proxy statement | Apr 15, 2011 | May 25, 2011 |
| DEF 14A | Proxy statement | Apr 23, 2010 | May 27, 2010 |
| DEF 14A | Proxy statement | Apr 13, 2009 | May 14, 2009 |
| DEF 14A | Proxy statement | Apr 16, 2008 | May 15, 2008 |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- HBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Holliston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1123494
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.